These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37186887)

  • 21. The immune response in tubercular uveitis and its implications for treatment: From anti-tubercular treatment to host-directed therapies.
    Putera I; Schrijver B; Ten Berge JCEM; Gupta V; La Distia Nora R; Agrawal R; van Hagen PM; Rombach SM; Dik WA
    Prog Retin Eye Res; 2023 Jul; 95():101189. PubMed ID: 37236420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Manifestations and Outcomes of Tubercular Uveitis in Taiwan-A Ten-Year Multicenter Retrospective Study.
    Lin CJ; Hsia NY; Hwang DK; Hwang YS; Chang YC; Lee YC; Hsu YR; Yeh PT; Lin CP; Chen HF; Jan WC; Chiang WY; Tsai ML
    Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334552
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1.
    Agrawal R; Gunasekeran DV; Grant R; Agarwal A; Kon OM; Nguyen QD; Pavesio C; Gupta V;
    JAMA Ophthalmol; 2017 Dec; 135(12):1318-1327. PubMed ID: 29075752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in tuberculosis-associated uveitis.
    Malalis JF; Goldstein DA
    Int Ophthalmol Clin; 2015; 55(2):37-46. PubMed ID: 25730618
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnostic Utility of QuantiFERON-Gold Testing in Patients with Ocular Inflammation in a Low-Endemic Tuberculosis Region.
    Xia J; Palestine AG; Reddy AK
    Am J Ophthalmol; 2024 Aug; 264():1-7. PubMed ID: 38518991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of QuantiFERON®-TB Gold test in diagnosis and management of suspected tubercular uveitis in India.
    Sudharshan S; Ganesh SK; Balu G; Mahalakshmi B; Therese LK; Madhavan HN; Biswas J
    Int Ophthalmol; 2012 Jun; 32(3):217-23. PubMed ID: 22527447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculosis: an under-diagnosed aetiological agent in uveitis with an effective treatment.
    Varma D; Anand S; Reddy AR; Das A; Watson JP; Currie DC; Sutcliffe I; Backhouse OC
    Eye (Lond); 2006 Sep; 20(9):1068-73. PubMed ID: 16215543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Host urinary biomarkers in HIV positive and HIV negative patients with tubercular uveitis and other uveitic diseases.
    van der Westhuizen DP; Snyders CI; Kidd M; Walzl G; Chegou NN; Smit DP
    Tuberculosis (Edinb); 2024 Sep; 148():102547. PubMed ID: 39084001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: a case-control study.
    Ang M; Hedayatfar A; Wong W; Chee SP
    Br J Ophthalmol; 2012 Mar; 96(3):332-6. PubMed ID: 21719564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of anti-tubercular therapy in patients with presumed ocular tuberculosis.
    Agrawal R; Gupta B; Gonzalez-Lopez JJ; Rahman F; Phatak S; Triantafyllopoulou I; Addison PK; Westcott M; Pavesio CE
    Ocul Immunol Inflamm; 2015 Feb; 23(1):40-6. PubMed ID: 25615809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular Tuberculosis--A Clinical Conundrum.
    Lee C; Agrawal R; Pavesio C
    Ocul Immunol Inflamm; 2016; 24(2):237-42. PubMed ID: 26110355
    [No Abstract]   [Full Text] [Related]  

  • 32. Ocular tuberculosis: Position paper on diagnosis and treatment management.
    Figueira L; Fonseca S; Ladeira I; Duarte R
    Rev Port Pneumol (2006); 2017; 23(1):31-38. PubMed ID: 27988134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculous Uveitis Presenting with a Bullous Exudative Retinal Detachment: A Case Report and Systematic Literature Review.
    Song JH; Koreishi AF; Goldstein DA
    Ocul Immunol Inflamm; 2019; 27(6):998-1009. PubMed ID: 29969330
    [No Abstract]   [Full Text] [Related]  

  • 34. Usefulness of the QuantiFERON test for the diagnosis of tubercular uveitis and the predictions of response to antituberculosis treatment.
    Danjou W; Pradat P; Jamilloux Y; Gerfaud-Valentin M; Kodjikian L; Trad S; Seve P
    Br J Ophthalmol; 2023 Apr; 107(4):500-504. PubMed ID: 34711577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tubercular Uveitis in Uveitis Cases in a High TB and HIV Setting: A Prospective Cohort Study.
    Alli HD; Ally N; Mayet I; Joseph L; Omar SV; Madhi SA
    Transl Vis Sci Technol; 2022 Jan; 11(1):9. PubMed ID: 35006262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normalised quantitative polymerase chain reaction for diagnosis of tuberculosis-associated uveitis.
    Barik MR; Rath S; Modi R; Rana R; Reddy MM; Basu S
    Tuberculosis (Edinb); 2018 May; 110():30-35. PubMed ID: 29779770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presumed Tuberculous uveitis: clinical features and management.
    Gargouri S; Kaibi I; Zone I; Khairallah M; Koubaa M; Ben Jemaa M; Feki J
    Tunis Med; 2019 Jan; 97(1):106-112. PubMed ID: 31535701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controversies in ocular tuberculosis.
    Ang M; Chee SP
    Br J Ophthalmol; 2017 Jan; 101(1):6-9. PubMed ID: 27815270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern of Recurrent Inflammation following Anti-tubercular Therapy for Ocular Tuberculosis.
    Multani PK; Modi R; Basu S
    Ocul Immunol Inflamm; 2022 Jan; 30(1):185-190. PubMed ID: 32644846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presumed tuberculous uveitis: diagnosis, management, and outcome.
    Sanghvi C; Bell C; Woodhead M; Hardy C; Jones N
    Eye (Lond); 2011 Apr; 25(4):475-80. PubMed ID: 21293496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.